
First published in 1984, this book examines corporate crime in the pharmaceutical industry and is based on extensive research, including interviews with 131 senior executives of international pharmaceutical companies. It covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs.
We publiceren alleen reviews die voldoen aan de voorwaarden voor reviews. Bekijk onze voorwaarden voor reviews.